Proton pump inhibitors

M R7 Pill - beige round

Pill with imprint M R7 is Beige, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Mylan Pharmaceuticals Inc.

Rabeprazole is used in the treatment of Barrett's Esophagus; Duodenal Ulcer; Erosive Esophagitis; Duodenal Ulcer Prophylaxis; GERD and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Rabeprazole (Rabeprazole [ ra-bep-ra-zole ])-M R7-20 mg-Beige-Round
Rabeprazole (Rabeprazole [ ra-bep-ra-zole ])-M R7-20 mg-Beige-Round
Rabeprazole (Rabeprazole [ ra-bep-ra-zole ])-M R7-20 mg-Beige-Round
Rabeprazole (Rabeprazole [ ra-bep-ra-zole ])-M R7-20 mg-Beige-Round

Rabeprazole
Generic Name: rabeprazole [ ra-bep-ra-zole ]
Imprint: M R7
Strength: 20 mg
Color: Beige
Size: N/A
Shape: Round
Availability: Prescription only
Drug Class: Proton pump inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-6709 (Discontinued)
Inactive Ingredients: Ammonia, Silicon dioxide, Croscarmellose sodium, FD&C Blue No. 2, FD&C Yellow No. 6, Magnesium oxide, Magnesium stearate, Mannitol, Medium-chain triglycerides, Methacrylic acid - ethyl acrylate copolymer (1:1) type a, Oleic acid, Polydextrose, Polysorbate 80, Sodium hydroxide, Sodium lauryl sulfate, Magnesium silicate, Titanium dioxide, Triacetin, Triethyl citrate, Ferrosoferric oxide, Propylene glycol,
Latest News
Related Drugs